redburn ceo conference 2013 - basf€¦ · this presentation may contain forward-looking statements...
TRANSCRIPT
We add value as one company
Oil & Gas
Agricultural Solutions
Functional Materials & Solutions
Performance Products
Chemicals
Value
Kurt Bock Chairman of the Board of Executive Directors Redburn 2013 CEO Conference London, December 03, 2013
BASF Capital Market Story December 2013 2
Cautionary note regarding forward-looking statements
This presentation may contain forward-looking statements that are subject to risks and uncertainties, including those pertaining to the anticipated benefits to be realized from the proposals described herein. Forward-looking statements may include, in particular, statements about future events, future financial performance, plans, strategies, expectations, prospects, competitive environment, regulation and supply and demand. BASF has based these forward-looking statements on its views and assumptions with respect to future events and financial performance. Actual financial performance could differ materially from that projected in the forward-looking statements due to the inherent uncertainty of estimates, forecasts and projections, and financial performance may be better or worse than anticipated. Given these uncertainties, readers should not put undue reliance on any forward-looking statements. The information contained in this presentation is subject to change without notice and BASF does not undertake any duty to update the forward-looking statements, and the estimates and assumptions associated with them, except to the extent required by applicable laws and regulations.
BASF Capital Market Story December 2013 3
Percentage of sales 2012**
** Not depicted here: ~5% of Group sales reported as ‘Other‘ * Restated numbers, reflecting IFRS 10/11 changes, new segment structure effective Jan. 1, 2013
BASF today – a well-balanced portfolio Total sales 2012: €72.1 billion*
BASF Capital Market Story October 2013 4
Business review
BASF strategy & strategic levers
BASF Capital Market Story December 2013 5
Enterprise value ~62 million US dollars
Acquisition successfully completed (October 31, 2013)
Verenium strengthens BASF‘s footprint in the enzyme growth market
Optimization of global production network
Reduction of 650 positions worldwide
Investment of €250 million in production and R&D
Transaction completed July 31, 2013
Increased production from 3,000 to ~40,000 boe per day in Norway
Compensation payment of ~781 million US dollars*
Important corporate developments
Transaction with Statoil completed
Restructuring in Pigments business
Acquisition of Verenium enzyme biotechnology
* Euro/dollar exchange rate July 31, 2013: €1 = $1.3275
BASF Capital Market Story December 2013 6
Robust 3rd quarter 2013 for BASF
Sales development Period Volumes Prices Portfolio Currencies
Q3’13 vs. Q3’12 6% (1%) 1% (5%)
Business performance Q3’13 vs. Q3’12 Q1-Q3’13 vs. Q1-Q3’12
Sales €17.7 billion +1.5% €55.8 billion +3%
EBITDA €2.5 billion +16% €7.8 billion (1%)
EBIT before special items €1.7 billion +15% €5.7 billion +6%
EBIT €1.7 billion +20% €5.6 billion (1%)
Net income €1.1 billion +18% €3.7 billion (4%)
Reported EPS €1.20 +19% €4.03 (4%)
Adjusted EPS €1.28 +10% €4.35 +1%
Operating cash flow €2.0 billion +21% €6.0 billion +19%
BASF Capital Market Story December 2013 7
0
1
2
3
4
2003 2004 2005 2006 2007 2008 2009** 2010 2011 2012 Q1-Q32013
Strong free cash flow generation
* Cash provided by operating activities less capex (in 2005 before CTA) ** 2009 adjusted for re-classification of settlement payments for currency derivatives
Free cash flow* in € billion
2.8 2.6
3.3 3.5
3.2
2.5
3.2
3.9 3.7
2.6 2.9
BASF Capital Market Story December 2013 8
Delivering attractive shareholder returns
Dividend of €2.60 per share for 2012
2003-2012: Average annual dividend increase of 16%
Attractive dividend yield of 3.7% in 2012**
Dividend yield above 3% in any given year since 2002, total payout almost €17 billion
* Dividend yield based on share price at year-end
Dividend payments
3.7% 3.2% 3.1% 4.1% 3.8% 7.0% 3.9%
Dividend yield* 4.6% 3.1%
2.50
0.70 0.85 1.00
1.50
1.95 1.951.70
2.20
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
2.60
3.7%
** Based on BASF share price of €71.15 on Dec. 28, 2012
Dividend per share in €
CAGR 16%
BASF Capital Market Story December 2013 9
We do not anticipate an acceleration of global economic growth in the 4th quarter of 2013
For the full year, BASF confirms its outlook: We strive to exceed the record levels in sales and EBIT before special items in a challenging economic environment
Our focus on growth markets and innovation, in combination with our measures to optimize our portfolio and to improve operational excellence, will contribute to this
We aim to earn a high premium on cost of capital in 2013
Outlook 2013
GDP: +2.0% (unchanged)
Industrial production: +2.7% (unchanged)
Chemical production: +3.1% (unchanged)
US$ / Euro: 1.30 (unchanged)
Oil price (US$ / bbl): 105 (unchanged)
Assumptions 2013
Outlook 2013
BASF Capital Market Story October 2013 10
Business review
BASF strategy & strategic levers
BASF Capital Market Story December 2013 11
Grow at least 2 percentage points above chemical production
Earn a premium on cost of capital of at least €2.0 billion on average p.a.
Profitability targets Growth targets
2015
2020
Sales ~€80 billion
Sales ~€110 billion
EBITDA ~€14 billion EPS ~€7.50
EBITDA ~€22 billion
Key financial targets 2015 / 2020 are ambitious
BASF Capital Market Story December 2013 12
Portfolio development Moving downstream towards customer industries
* Agriculture, Construction, Consumer Goods, Health & Nutrition, Electronics, Energy & Resources, Transportation ** Sales excluding Oil & Gas. Targets were published on November 29, 2011.
Functionalized Materials & Solutions Customized Products Classical Chemicals
2020 in % of sales**
Chemical Industry First customer industries*
2010 in % of sales**
~ 40%
~ 30% ~ 70%
2001 in % of sales**
~ 50%
~ 60%
~ 50%
BASF Capital Market Story December 2013 13
Engineering plastics Electronic chemicals Catalysts Construction chemicals Water-based resins Pigments Plastic additives Oil & Gas Personal care & food Battery materials Functional crop care Omega-3 fatty acids Enzymes
BASF core business
Strong partnerships
Gazprom Statoil Monsanto Petronas Shell Sinopec Total
Selected transactions 2001 − today*
Acquisitions
~ €16bn sales ~ €10bn sales**
Divestitures
Pharma Fibers Printing systems Polyolefins Polystyrene Americas Agro generics Vitamins premix Fertilizers Styrenics (transferred into
Styrolution JV on Oct. 1, 2011)
Construction equipment, flooring systems
** Without Styrenics
Portfolio development Towards more market driven and innovative businesses
* Only closed deals have been considered
BASF Capital Market Story December 2013 14
Strong commitment to innovation Innovations for a sustainable future
Key facts €1.7 bn R&D expenditures in
2012, further increase planned for 2013
~10,500 employees in R&D
~3,000 projects
Research Verbund: About 600 cooperation partners with universities, start-ups and industry
Target 2015 and 2020: – €10 bn in sales, €2.5 bn
EBITDA from innovations younger 5 years
– €30 bn in sales, €7 bn EBITDA from innovations younger 10 years
BASF Capital Market Story December 2013 15
Joint development with adidas, illustrating our customer focus
New cushioning material, provides highest energy return in the running industry
Solid granular material* is ‘blown up’, turned into 1000’s of small energy capsules
With their unique cell structure, these energy capsules store and unleash energy more efficiently in every stride
New shoe is available in stores since February, 2013
Key facts
Photo: adidas
* TPU (Thermoplastic polyurethane)
Innovation with adidas: Infinergy™ Technology competencies combined with customer know-how
BASF Capital Market Story December 2013 16
BASF growth fields focus on enabling technologies
Health & Nutrition
Consumer Goods Construction Transportation Electronics Energy &
Resources Agriculture
Customer industries
Water solutions
Heat management
Enzymes Plant biotechnology
Batteries for mobility
Lightweight composites
Functional crop care
Medical Organic electronics
Growth Fields*
E-Power management
Wind energy
Resources, Environment & Climate Food & Nutrition Quality of life
Chemistry as enabler
* Including growth fields still under evaluation
Materials Systems & Nanotechnology
Raw Material Change
White Biotechnology
Techno-logy
fields
BASF Capital Market Story October 2013 17
Enabling technology: Battery Materials Driving the future of electromobility
* Driving range (km) of an electric car (with a 100kg battery)
0 100 200 300 400
Li-S**
HE/HV
Li-ion
Generation 2: Current Generation 3: 2017 Generation 4: 2022+
BASF‘s technology roadmap- Battery materials for today and tomorrow
Li-ion HE/HV Li-ion Li-S
Driving range (km)*
Technology
From Li-ion to Lithium-sulfur
Business potential 2020 Strategic relevant market: >€5 billion globally
(~€4 billion in Asia Pacific)
Sales potential BASF: >€500 million globally (~€350 million in Asia Pacific)
BASF activities Start of business unit „Battery Materials“ in 2012
Several technology-driven acquisitions undertaken
Three-digit million euro invest for R&D and production
R&D network with universities / industrial partners
BASF Capital Market Story December 2013 18
Thereof investments in emerging markets Total investments
35-45%
15-20
30-40%
~15
2006 – 2010 2011 – 2015 2016 – 2020
10.9
~20%
Investments … will boost future organic growth
Future investments in € billion
BASF Capital Market Story December 2013 19
* Memorandum of Understanding signed
TDI plant Ludwigshafen, Germany
Expansion oil & gas activities
Aroma Ingredients Kuantan, Malaysia
Investments Major projects
Expansion Verbund site Nanjing, China*
MDI plant Chongqing, China
Acrylic acid complex Camacari, Brazil
BASF Capital Market Story December 2013 20
BASF aims to further increase its sales share from emerging markets
*BASF definition: Developed markets include EU15, Norway, Switzerland, North America, Japan, Australia, New Zealand
** Sales excluding Oil & Gas
2020 in % of sales**
2012 in % of sales
(€62bn**)
2001 in % of sales
(€28 bn**)
Emerging markets Developed markets*
~ 65%
~ 55% ~ 45%
~ 78%
~ 35%
~ 22%
BASF Capital Market Story December 2013 21
0
1.000
2.000
3.000
2012 2015
Former cost saving programs NEXT STEP
Operational excellence programs STEP program on track: ~€1 billion earnings contribution by 2015
Annual earnings contribution in € million
Targeted annual earnings contri-bution of ~€1 billion by end of 2015
Project timeline: 2012–2015 Program is on track Measures to optimize processes
and structures in all regions, e.g. – manufacturing, maintenance – supply chain – engineering, best-cost country
sourcing One-time costs & investments:
~€1 billion
NEXT Program
STrategic Excellence Program ‘STEP’
NEXT program successfully completed
Annual earnings contribution of ~€1 billion achieved in 2012
BASF Capital Market Story December 2013 22
22